Table 2.
Variable | Total | No. of patients (%) | P‐value | |
---|---|---|---|---|
miR194‐negative | miR194‐positive | |||
Sex | ||||
Male | 152 | 26 (17.1) | 126 (82.9) | 0.227b |
Female | 82 | 20 (24.4) | 62 (75.6) | |
Age (Years) | ||||
≤61 | 117 | 23 (19.7) | 94 (80.3) | 1.000b |
>61 | 117 | 23 (19.7) | 94 (80.3) | |
Laterality | ||||
Left | 132 | 26 (19.7) | 106 (80.3) | 1.000b |
Right | 102 | 20 (19.6) | 82 (80.4) | |
Tumor size (cm) | ||||
≤4.0 | 79 | 15 (19.0) | 64 (81.0) | 0.863b |
>4.0 | 154 | 32 (20.8) | 122 (79.2) | |
ΤΝΜ stage | ||||
I | 88 | 14 (15.9) | 74 (84.1) | 0.343c |
ΙΙ | 19 | 4 (21.1) | 15 (78.9) | |
ΙΙΙ | 24 | 7 (29.2) | 17 (70.8) | |
IV | 32 | 9 (28.1) | 23 (71.9) | |
Tumor grade | ||||
I | 14 | 5 (35.7) | 9 (64.3) | 0.016c |
II | 96 | 17 (17.7) | 79 (82.3) | |
III | 87 | 11 (12.6) | 76 (87.4) | |
IV | 31 | 11 (35.5) | 20 (64.5) |
Status is unknown.
Cut‐off point: 0.28 RQ Units, equal to the 20th percentile.
Calculated using Fisher's Exact test.
Calculated using Pearson Chi‐square test.